FDA recall D-0582-2024 · initiated Jul 2, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
CGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltered bulk for decitabine for injection.